Article Details

R&D plans by drug giant AstraZeneca shot in arm for Hong Kong's biomedical hub bid

Retrieved on: 2023-11-28 00:15:49

Tags for this article:

Click the tags to see associated articles and topics

R&D plans by drug giant AstraZeneca shot in arm for Hong Kong's biomedical hub bid. View article details on hiswai:

Excerpt

AstraZeneca decision follows Hong Kong labs move by UN vaccine body and Cambridge University.

Article found on: www.scmp.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up